Wernicke Disease in Infants (Infantile Thiamine Deficiency)

Overview

Wernicke disease in infants—also called infantile thiamine (vitamin B1) deficiency or “Wernicke encephalopathy in early life”—is a rare, but potentially fatal, neurological disorder caused by an insufficient supply of thiamine. The condition results in acute damage to the brain’s diencephalon, brainstem, and cerebellum, leading to a classic triad of ophthalmoplegia, ataxia, and altered mental status. While classic Wernicke encephalopathy is most often associated with chronic alcohol misuse in adults, infants can develop the disease when maternal or dietary thiamine is lacking.

Who it affects: Newborns and infants up to 12 months, especially those who are breast‑fed by thiamine‑deficient mothers, or those fed with thiamine‑poor formulas (e.g., unfortified rice‑based or soy‑based formulas). Pre‑term infants, infants with chronic diarrhea, or those receiving prolonged parenteral nutrition without adequate vitamin supplementation are also at higher risk.

Prevalence: True incidence is difficult to capture because many low‑resource settings lack diagnostic capacity. In Thailand, a 2018 surveillance study identified 31 confirmed cases among ~1.4 million live births (≈2.2 per 100,000) during a 5‑year period, with clusters linked to maternal malnutrition during the rainy season (Mayo Clinic, 2022). In high‑income countries the condition is exceedingly rare—estimated <1 case per million infants—but sporadic outbreaks still occur after natural disasters or in refugee camps where nutrient‑dense foods are scarce.

Symptoms

The clinical picture can be subtle at first, progressing rapidly over hours to days. The classic “Wernicke triad” is less common in infants (only ~30 % present with all three), so clinicians must consider a broader symptom set.

Neurological

• Ophthalmoplegia / Nystagmus: Incomplete eye movements, double‑vision‑like staring, or rapid, involuntary eye jerks.
• Ataxia: Poor head control, unsteady sitting or crawling, inability to maintain balance when supported.
• Altered mental status: Irritability, lethargy, decreased responsiveness, or seizures.
• Hypotonia: Floppy muscles, especially in the trunk and limbs.
• Failure to thrive: Poor weight gain despite adequate caloric intake.

Gastrointestinal & Metabolic

• Vomiting or poor feeding.
• Diarrhea (which can exacerbate thiamine loss).
• Metabolic acidosis (due to impaired carbohydrate metabolism).

Other Systemic Signs

• Cardiovascular instability – tachycardia, low blood pressure.
• Skin pallor or mottling.
• Hyperthermia or hypothermia (temperature dysregulation).

Causes and Risk Factors

Thiamine is an essential water‑soluble vitamin required for carbohydrate metabolism, nerve conduction, and synthesis of neurotransmitters. Deficiency occurs when intake, absorption, or utilization is inadequate.

Primary Causes

• Maternal deficiency: Mothers with poor dietary thiamine (e.g., diets dominated by polished rice, low‑protein staples) may have low breast‑milk thiamine. Studies from Laos and Bangladesh report infant deficiency rates of 13–20 % when maternal intake <0.5 mg/day (WHO, 2021).
• Inadequate formula: Homemade or commercial formulas not fortified with B‑vitamins, especially in low‑income regions.
• Parenteral nutrition without supplementation: Premature infants receiving >2 weeks of total‑parenteral nutrition (TPN) without added thiamine are at risk.
• Chronic gastrointestinal loss: Prolonged diarrhea, vomiting, or malabsorption syndromes (e.g., celiac disease) deplete thiamine stores.

Risk Factors

• Pre‑term birth (<37 weeks gestation)
• Low birth weight (<2.5 kg)
• Maternal alcoholism or substance abuse
• Severe malnutrition or protein‑energy wasting in the mother
• Genetic disorders affecting thiamine transport (e.g., thiamine‑responsive megaloblastic anemia)
• Prolonged fasting or “clean‑seeking” diets (e.g., exclusive breastfeeding during maternal fasting periods)
• Natural disasters that disrupt food supply (e.g., floods in South Asia)

Diagnosis

Early diagnosis is critical because neurological injury can become permanent within 48 hours of onset. Diagnosis relies on a combination of clinical suspicion, laboratory testing, and neuro‑imaging.

Clinical Assessment

• Detailed dietary history of infant and mother.
• Physical exam focusing on eye movements, coordination, and mental status.

Laboratory Tests

• Whole‑blood thiamine (thiamine diphosphate) level: The gold standard; <10 nmol/L is diagnostic (NIH, 2023).
• Urinary thiamine excretion: Helpful for rapid screening; low levels support diagnosis.
• Serum lactate & pyruvate: Elevated in thiamine deficiency due to impaired pyruvate dehydrogenase.
• Basic metabolic panel to assess acidosis, electrolytes, and glucose.

Neuro‑imaging

• MRI: Shows symmetric hyperintensities on T2/FLAIR in the mamillary bodies, thalamus, periaqueductal gray, and cerebellar vermis. MRI is >80 % sensitive and can distinguish Wernicke encephalopathy from other infantile encephalopathies.
• CT is less sensitive but may be used in emergent settings to rule out hemorrhage.

Diagnostic Criteria (adapted from Caine 1997)

Diagnosis is confirmed when any two of the following are present:

1. Oculomotor dysfunction (nystagmus, ophthalmoplegia)
2. Ataxia or gait disturbances
3. Altered mental status/confusion
4. Thiamine deficiency documented by laboratory testing

Because infants often cannot verbalize confusion, clinicians place greater weight on eye findings, ataxia, and documented low thiamine.

Treatment Options

Thiamine replacement is a medical emergency. Prompt therapy can reverse symptoms and prevent permanent damage.

Pharmacologic Therapy

• Intravenous thiamine: 100 mg diluted in 0.9 % saline, administered over 30 minutes, every 8 hours for the first 48 hours. This high‑dose regimen is recommended by the American Academy of Pediatrics (AAP, 2022).
• After 48 hours, if clinical improvement is evident, switch to intramuscular thiamine 50 mg daily for 5–7 days, then transition to oral thiamine 10–25 mg daily for at least 4 weeks.
• Co‑administration of magnesium sulfate (if low) may improve thiamine utilization.

Supportive Care

• Correct dehydration, electrolyte imbalances, and metabolic acidosis.
• Provide glucose cautiously—rapid glucose infusion can precipitate seizures if thiamine is not already given.
• Manage seizures with phenobarbital or levetiracetam, but only after thiamine has been administered.
• Monitor cardiac status (ECG, blood pressure) for potential thiamine‑related cardiomyopathy.

Procedures

• In cases of severe cerebral edema, neurosurgical decompression may be required, although this is rare.

Lifestyle / Nutritional Interventions

• Switch to a thiamine‑fortified formula or continue exclusive breastfeeding while ensuring the mother receives a daily 100 mg thiamine supplement.
• Educate caregivers on balanced complementary foods after 6 months (e.g., addition of fortified cereals, legumes, lean meats).

Living with Wernicke Disease in Infants (Infantile Thiamine Deficiency)

Even after acute treatment, families may need ongoing support to ensure normal development.

Follow‑up Care

• Neurology follow‑up at 1 week, 1 month, and 6 months post‑discharge.
• Developmental screening (Bayley Scales of Infant Development) to detect subtle motor or cognitive delays.
• Repeat MRI at 3 months if neurological deficits persist.

Nutrition Management

• Maintain daily oral thiamine 10–25 mg until the infant is at least 12 months old, then continue per pediatric guidelines.
• Incorporate thiamine‑rich foods after weaning: fortified cereals, whole grains, pork, beans, nuts, and eggs.
• For breastfeeding mothers, prescribe 100 mg thiamine orally daily for at least 3 months postpartum.

Home Strategies

• Keep a medication chart that lists the dosage and timing of thiamine.
• Monitor feeding patterns; note any sudden decrease in appetite or increased irritability.
• Maintain a safe environment to reduce fall risk as coordination improves.
• Engage in age‑appropriate physical therapy to strengthen gross motor skills.

Psychosocial Support

• Connect families with community nutrition programs (e.g., WIC in the United States, UN World Food Programme in low‑income settings).
• Provide counseling for parental anxiety—parents may feel guilt after a “preventable” condition.

Prevention

Prevention focuses on ensuring adequate thiamine intake for both mother and infant.

• Maternal supplementation: 1.2 mg/day of thiamine during pregnancy is recommended; high‑risk mothers (e.g., malnourished, chronic alcohol users) should receive 100 mg/day under medical supervision.
• Fortified infant formulas: Use only formulas that meet FDA/EFSA fortification standards (≥0.5 mg/L thiamine).
• Breast‑milk monitoring: In areas with known deficiencies, test maternal thiamine levels at the first prenatal visit and again in the third trimester.
• Food security interventions: Distribute fortified rice or wheat flour in disaster‑prone regions.
• Education: Public‑health campaigns emphasizing the importance of a varied diet with whole grains, legumes, and lean meat.

Complications

If left untreated, infantile Wernicke disease can lead to irreversible damage.

• Permanent neurological deficits: Cerebellar ataxia, oculomotor palsy, or intellectual disability.
• Korsakoff syndrome: Though rare in infants, chronic memory impairment may develop.
• Cardiomyopathy: Thiamine deficiency can cause high‑output heart failure (wet beriberi).
• Seizure disorder: Recurrent seizures may persist even after thiamine repletion.
• Growth retardation: Ongoing malnutrition syndromes.
• Death: Mortality rates in untreated infants range from 20–30 % in reported outbreaks (CDC, 2020).

When to Seek Emergency Care

---

Sources: Mayo Clinic (2022); Centers for Disease Control and Prevention (2020); National Institutes of Health – Office of Dietary Supplements (2023); World Health Organization, Guidelines on Vitamin B1 Supplementation (2021); American Academy of Pediatrics, Clinical Report on Neonatal Nutrition (2022); Cleveland Clinic, Wernicke Encephalopathy (2023).